Alterity Therapeutics Limited: February 2025 Form 6-K Filing Insights

Here are the key insights extracted from the provided financial report section:

1. Filing Information:

• Type of Filing: Form 6-K
• Date of Report: February 18, 2025
• Reporting Period: For the month of February 2025
  

2. Company Information:

• Registrant: Alterity Therapeutics Limited
• Address: Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia

3. Regulatory Compliance:

• The report is filed pursuant to Rule 13a-16 or 15d-163 under the Securities Exchange Act of 1934.

4. Annual Report Compliance:

• The registrant indicated that it files annual reports under Form 20-F and does not file under Form 40-F.

5. Incorporation of Other Filings:

• This Form 6-K is being incorporated by reference into several registration statements:
• • Form S-8 (with multiple file numbers)
  • Form F-3 (with multiple file numbers)

6. Exhibits Included:

• The report includes an exhibit labeled "99.1" which is a "Notice Under Section 708A".

7. Signature:

• The report is signed by Geoffrey P. Kempler, who is the Chairman of Alterity Therapeutics Limited.

8. Filing Date:

• The date of the report signature is February 18, 2025.

The report primarily serves as a regulatory compliance submission for Alterity Therapeutics Limited, detailing its filing status and associated documents.